Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C8H9N5O4 |
| Molecular Weight | 239.1882 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=NC2=C(N=CN2COCC(O)=O)C(=O)N1
InChI
InChIKey=MICNQLKUSOVNNG-UHFFFAOYSA-N
InChI=1S/C8H9N5O4/c9-8-11-6-5(7(16)12-8)10-2-13(6)3-17-1-4(14)15/h2H,1,3H2,(H,14,15)(H3,9,11,12,16)
| Molecular Formula | C8H9N5O4 |
| Molecular Weight | 239.1882 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Acyclovir nephrotoxicity: a case report highlighting the importance of prevention, detection, and treatment of acyclovir-induced nephropathy. | 2010 |
|
| Influence of ALDH2 genetic polymorphisms on aciclovir pharmacokinetics following oral administration of valaciclovir in Japanese end-stage renal disease patients. | 2008 |
|
| [Risk of CNS adverse effects of aciclovir and valaciclovir. Watch the renal function in treatment of herpes simplex and herpes zoster]. | 2007-08-07 |
|
| Acyclovir-induced neuropsychosis successfully recovered after immediate hemodialysis in an end-stage renal disease patient. | 2007-08 |
|
| Development, evaluation and application of an isocratic high-performance liquid chromatography (HPLC) assay for the simultaneous determination of aciclovir and its metabolite 9-carboxymethoxymethylguanine in human serum and cerebrospinal fluid. | 2007-07 |
|
| The aciclovir metabolite CMMG is detectable in the CSF of subjects with neuropsychiatric symptoms during aciclovir and valaciclovir treatment. | 2006-05 |
|
| Aciclovir and valaciclovir neurotoxicity in patients with renal failure. | 2003-12 |
|
| High serum concentrations of the acyclovir main metabolite 9-carboxymethoxymethylguanine in renal failure patients with acyclovir-related neuropsychiatric side effects: an observational study. | 2003-06 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:49:56 GMT 2025
by
admin
on
Mon Mar 31 22:49:56 GMT 2025
|
| Record UNII |
N28227W35C
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
N28227W35C
Created by
admin on Mon Mar 31 22:49:56 GMT 2025 , Edited by admin on Mon Mar 31 22:49:56 GMT 2025
|
PRIMARY | |||
|
9-Carboxymethoxymethylguanine
Created by
admin on Mon Mar 31 22:49:56 GMT 2025 , Edited by admin on Mon Mar 31 22:49:56 GMT 2025
|
PRIMARY | |||
|
DTXSID40230501
Created by
admin on Mon Mar 31 22:49:56 GMT 2025 , Edited by admin on Mon Mar 31 22:49:56 GMT 2025
|
PRIMARY | |||
|
135508007
Created by
admin on Mon Mar 31 22:49:56 GMT 2025 , Edited by admin on Mon Mar 31 22:49:56 GMT 2025
|
PRIMARY | |||
|
80685-22-9
Created by
admin on Mon Mar 31 22:49:56 GMT 2025 , Edited by admin on Mon Mar 31 22:49:56 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE |
MAJOR
URINE
|